Short answer
Health Catalyst, Inc. (HCAT) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $56M (down 26.3% year over year) with net income of $40M.
Q3 2026 key financials · XBRL
- Revenue
- $56M
- −26.3% YoY · −20.2% QoQ
- Net income
- $40M
- +282.2% YoY · +199.9% QoQ
- Operating margin
- 89.1%
- EPS (diluted)
- $0.57
- +283.9% YoY · +205.6% QoQ
Source: XBRL data from the Health Catalyst, Inc. (HCAT) Q3 2026 10-Q on SEC EDGAR. USD.
Health Catalyst, Inc. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 revenue $56.3M, down 26% YoY from $76.3M, driven by Vitalware divestiture and DOS-to-Ignite churn
- Total gross margin 31% vs 39% YoY; net income $40.5M vs $22.2M loss, including $65.9M Vitalware gain
- Technology revenue $40.7M, down 22%; professional services $15.6M, down 36%, the weaker segment
- Cash from operations $16.9M vs $9.2M used YoY; $144.5M Vitalware proceeds funded debt repayment
- Near-term headwinds: Medicaid cuts, elongated sales cycles, Ignite migration churn, and lower technology margins through 2027
Risk Factors
- Newly added regulatory risk: OBBBA Medicaid funding reductions enacted July 2025 could reduce enrollment and covered services
- Most material update: Project Nexus reduced global workforce approximately 7% by second quarter 2026, risking execution and employee attrition
- AI compliance risk: California, Colorado, Texas, and Utah enacted or advanced requirements affecting AI safeguards, disclosures, and accountability
- Near-term operating risk: DOS-to-Ignite migration continues causing client churn, downselling, and smaller bookings
- Financial concentration risk: Three largest clients represented 13.6% of 2025 revenue, increasing exposure to renegotiations or loss of major accounts
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Health Catalyst, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.